LEONARD GIANNONE, M.D.; DAVID H. JOHNSON, M.D.; KENNETH R. HANDE, M.D.; F. ANTHONY GRECO, M.D.
GIANNONE L, JOHNSON DH, HANDE KR, GRECO FA. Favorable Prognosis of Brain Metastases in Small Cell Lung Cancer. Ann Intern Med. 1987;106:386-389. doi: 10.7326/0003-4819-106-3-386
Download citation file:
Published: Ann Intern Med. 1987;106(3):386-389.
Brain metastases are found at diagnosis in 10% of patients with small cell lung cancer. To clarify the effect of central nervous system metastases on prognosis, the records of 429 patients with small cell lung cancer were reviewed. Forty-three patients (10%) presented with brain metastases. In 18 patients the brain was the only site of metastatic disease, whereas the remaining 25 patients had at least one additional metastatic site. Forty-one of forty-three patients were treated with combination chemotherapy and cranial radiotherapy. Systemic response rates were similar for both groups. Twenty-seven patients underwent repeat central nervous system staging: 19 (70%) had a complete response, 4 (15%) a partial response, and 4 (15%) no response. Median survival of patients with only one site of metastatic disease was 11 months; patients with additional sites lived 5 months (p = 0.153). Survival in patients with only one site is similar to that in patients with limited disease (11 compared with 13 months; p = 0.074).
Learn more about subscription options.
Register Now for a free account.
Hematology/Oncology, Lung Cancer, Neurology, Pulmonary/Critical Care.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only